ENST00000507735.6:c.273G>C

Variant summary

Our verdict is Benign. The variant received -13 ACMG points: 0P and 13B. BP4_StrongBP6_Very_StrongBP7

The ENST00000507735.6(PALLD):​c.273G>C​(p.Pro91Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. P91P) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0016 ( 0 hom., cov: 30)
Exomes 𝑓: 0.028 ( 0 hom. )
Failed GnomAD Quality Control

Consequence

PALLD
ENST00000507735.6 synonymous

Scores

3

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: -0.600

Publications

1 publications found
Variant links:
Genes affected
PALLD (HGNC:17068): (palladin, cytoskeletal associated protein) This gene encodes a cytoskeletal protein that is required for organizing the actin cytoskeleton. The protein is a component of actin-containing microfilaments, and it is involved in the control of cell shape, adhesion, and contraction. Polymorphisms in this gene are associated with a susceptibility to pancreatic cancer type 1, and also with a risk for myocardial infarction. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2009]
CBR4 (HGNC:25891): (carbonyl reductase 4) Enables several functions, including 3-oxoacyl-[acyl-carrier-protein] reductase (NADPH) activity; NADPH binding activity; and NADPH dehydrogenase (quinone) activity. Involved in fatty acid biosynthetic process; glycoside metabolic process; and protein tetramerization. Located in mitochondrial matrix. Part of oxidoreductase complex. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript ENST00000507735.6, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -13 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.64).
BP6
Variant 4-168878164-G-C is Benign according to our data. Variant chr4-168878164-G-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 215805.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-0.6 with no splicing effect.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000507735.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
NM_001166108.2
MANE Select
c.1965-12758G>C
intron
N/ANP_001159580.1Q8WX93-9
PALLD
NM_001166110.2
c.273G>Cp.Pro91Pro
synonymous
Exon 2 of 12NP_001159582.1Q8WX93-4
PALLD
NM_016081.4
c.1965-12758G>C
intron
N/ANP_057165.3

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PALLD
ENST00000507735.6
TSL:1
c.273G>Cp.Pro91Pro
synonymous
Exon 2 of 12ENSP00000424016.1Q8WX93-4
PALLD
ENST00000505667.6
TSL:1 MANE Select
c.1965-12758G>C
intron
N/AENSP00000425556.1Q8WX93-9
PALLD
ENST00000261509.10
TSL:1
c.1965-12758G>C
intron
N/AENSP00000261509.6Q8WX93-2

Frequencies

GnomAD3 genomes
AF:
0.00156
AC:
161
AN:
102898
Hom.:
0
Cov.:
30
show subpopulations
Gnomad AFR
AF:
0.00299
Gnomad AMI
AF:
0.00179
Gnomad AMR
AF:
0.00124
Gnomad ASJ
AF:
0.000379
Gnomad EAS
AF:
0.00175
Gnomad SAS
AF:
0.00171
Gnomad FIN
AF:
0.00415
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000644
Gnomad OTH
AF:
0.00147
GnomAD2 exomes
AF:
0.0208
AC:
1188
AN:
57246
AF XY:
0.0161
show subpopulations
Gnomad AFR exome
AF:
0.112
Gnomad AMR exome
AF:
0.0803
Gnomad ASJ exome
AF:
0.0196
Gnomad EAS exome
AF:
0.0283
Gnomad FIN exome
AF:
0.0132
Gnomad NFE exome
AF:
0.0110
Gnomad OTH exome
AF:
0.0211
GnomAD4 exome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.0280
AC:
10284
AN:
367294
Hom.:
0
Cov.:
25
AF XY:
0.0270
AC XY:
4998
AN XY:
185078
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.0451
AC:
323
AN:
7168
American (AMR)
AF:
0.131
AC:
1123
AN:
8602
Ashkenazi Jewish (ASJ)
AF:
0.0401
AC:
288
AN:
7176
East Asian (EAS)
AF:
0.0274
AC:
88
AN:
3216
South Asian (SAS)
AF:
0.0277
AC:
895
AN:
32364
European-Finnish (FIN)
AF:
0.0486
AC:
265
AN:
5454
Middle Eastern (MID)
AF:
0.0372
AC:
39
AN:
1048
European-Non Finnish (NFE)
AF:
0.0235
AC:
6769
AN:
288510
Other (OTH)
AF:
0.0359
AC:
494
AN:
13756
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.259
Heterozygous variant carriers
0
1281
2561
3842
5122
6403
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
222
444
666
888
1110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Data not reliable, filtered out with message: AS_VQSR
AF:
0.00155
AC:
160
AN:
102930
Hom.:
0
Cov.:
30
AF XY:
0.00139
AC XY:
70
AN XY:
50308
show subpopulations
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00299
AC:
78
AN:
26100
American (AMR)
AF:
0.00124
AC:
13
AN:
10460
Ashkenazi Jewish (ASJ)
AF:
0.000379
AC:
1
AN:
2636
East Asian (EAS)
AF:
0.00175
AC:
6
AN:
3420
South Asian (SAS)
AF:
0.00171
AC:
5
AN:
2918
European-Finnish (FIN)
AF:
0.00415
AC:
23
AN:
5536
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
232
European-Non Finnish (NFE)
AF:
0.000624
AC:
31
AN:
49696
Other (OTH)
AF:
0.00146
AC:
2
AN:
1372
⚠️ The allele balance in gnomAD version 4 Genomes is significantly skewed from the expected value of 0.5. (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.254
Heterozygous variant carriers
0
22
44
65
87
109
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0102
Hom.:
0

ClinVar

ClinVar submissions
Significance:Benign/Likely benign
Revision:criteria provided, multiple submitters, no conflicts
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
3
not specified (3)
-
-
1
not provided (1)
-
-
1
Pancreatic adenocarcinoma (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.64
CADD
Benign
7.1
DANN
Benign
0.68
PhyloP100
-0.60
Mutation Taster
=89/11
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs777359545;
hg19: chr4-169799315;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.